YD Bio (NASDAQ:YDES) Sees Large Volume Increase – Still a Buy?

YD Bio Limited (NASDAQ:YDES) saw unusually-high trading volume on Friday. 433,562 shares were traded during mid-day trading, an increase of 201% from the previous session’s volume of 144,131 shares. The stock last traded at $7.8650 and had previously closed at $7.81.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of YD Bio to a “hold” rating in a research note on Saturday, September 26th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

YD Bio Stock Up 3.3%

The stock has a 50 day moving average price of $3.74 and a two-hundred day moving average price of $4.16.

YD Bio (NASDAQ:YDES) last posted its earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.42 million for the quarter.

Institutional Trading of YD Bio

An institutional investor recently raised its position in YD Bio stock. Cypress Capital Management LLC WY lifted its holdings in YD Bio Limited (NASDAQ:YDES) by 9.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,690 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the period. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 at the end of the most recent reporting period.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.